150 related articles for article (PubMed ID: 15922890)
41. [Treatment of peritoneal carcinomatosis from colorectal and appendiceal cancer by extensive cytoreductive surgery combined with hyperthermic intraoperative intraperitoneal chemotherapy].
Legendre H; Delaunoit T; Chassaing C; Pector JC
Rev Med Brux; 2005; 26(5):439-44. PubMed ID: 16318097
[TBL] [Abstract][Full Text] [Related]
42. [Cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion for peritoneal carcinomatosis caused by recurrent inflammatory myofibroblastic sarcoma: a case report and review of the literature].
Mátrai Z; Péley G; Kovács T; Rényi VF; Szívós E; Szabó E; Vereczkey I; Török K; Köves I
Orv Hetil; 2006 Jan; 147(4):147-58. PubMed ID: 16515023
[TBL] [Abstract][Full Text] [Related]
43. Laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) for the treatment of malignant ascites secondary to unresectable peritoneal carcinomatosis from advanced gastric cancer.
Facchiano E; Scaringi S; Kianmanesh R; Sabate JM; Castel B; Flamant Y; Coffin B; Msika S
Eur J Surg Oncol; 2008 Feb; 34(2):154-8. PubMed ID: 17640844
[TBL] [Abstract][Full Text] [Related]
44. Surgical treatment of peritoneal carcinomatosis from well-differentiated digestive endocrine carcinomas.
Elias D; Sideris L; Liberale G; Ducreux M; Malka D; Lasser P; Duvillard P; Baudin E
Surgery; 2005 Apr; 137(4):411-6. PubMed ID: 15800487
[TBL] [Abstract][Full Text] [Related]
45. Outcomes of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for peritoneal mesothelioma: the Australian experience.
Chua TC; Yan TD; Morris DL
J Surg Oncol; 2009 Feb; 99(2):109-13. PubMed ID: 19016259
[TBL] [Abstract][Full Text] [Related]
46. Perioperative morbidity and quality of life in long-term survivors following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Schmidt U; Dahlke MH; Klempnauer J; Schlitt HJ; Piso P
Eur J Surg Oncol; 2005 Feb; 31(1):53-8. PubMed ID: 15642426
[TBL] [Abstract][Full Text] [Related]
47. Cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy improves survival in selected patients with peritoneal carcinomatosis from abdominal and pelvic malignancies: results of 21 cases.
Yang XJ; Li Y; al-shammaa Hassan AH; Yang GL; Liu SY; Lu YL; Zhang JW; Yonemura Y
Ann Surg Oncol; 2009 Feb; 16(2):345-51. PubMed ID: 19018599
[TBL] [Abstract][Full Text] [Related]
48. Survival analysis of pseudomyxoma peritonei patients treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.
Smeenk RM; Verwaal VJ; Antonini N; Zoetmulder FA
Ann Surg; 2007 Jan; 245(1):104-9. PubMed ID: 17197972
[TBL] [Abstract][Full Text] [Related]
49. Use of hyperthermic intraperitoneal chemotherapy (HIPEC) in management of peritoneal carcinomatosis from colorectal origin.
Ceelen WP
Surg Technol Int; 2005; 14():125-30. PubMed ID: 16525964
[TBL] [Abstract][Full Text] [Related]
50. [The techniques of peritonectomy and hyperthermic intraperitoneal chemotherapy].
Lang SA; Glockzin G; Dahlke MH; Popp FC; Agha A; Schlitt HJ; Piso P
Zentralbl Chir; 2009 Sep; 134(5):443-9. PubMed ID: 19492282
[TBL] [Abstract][Full Text] [Related]
51. Cytoreductive surgery and intraperitoneal chemotherapy for peritoneal mesothelioma.
Yano H; Moran BJ; Cecil TD; Murphy EM
Eur J Surg Oncol; 2009 Sep; 35(9):980-5. PubMed ID: 18977109
[TBL] [Abstract][Full Text] [Related]
52. Diffuse malignant peritoneal mesothelioma: Failure analysis following cytoreduction and hyperthermic intraperitoneal chemotherapy (HIPEC).
Baratti D; Kusamura S; Cabras AD; Dileo P; Laterza B; Deraco M
Ann Surg Oncol; 2009 Feb; 16(2):463-72. PubMed ID: 19082859
[TBL] [Abstract][Full Text] [Related]
53. The role of cytoreductive surgery alone for the treatment of peritoneal carcinomatosis of colorectal origin. A retrospective analysis with regard to multimodal treatments.
Scaringi S; Leo F; Canonico G; Batignani G; Ficari F; Tonelli F
Hepatogastroenterology; 2009; 56(91-92):650-5. PubMed ID: 19621673
[TBL] [Abstract][Full Text] [Related]
54. Histological response of peritoneal carcinomatosis after hyperthermic intraperitoneal chemoperfusion (HIPEC) in experimental investigations.
Pelz JO; Doerfer J; Dimmler A; Hohenberger W; Meyer T
BMC Cancer; 2006 Jun; 6():162. PubMed ID: 16792796
[TBL] [Abstract][Full Text] [Related]
55. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer.
da Silva RG; Sugarbaker PH
J Am Coll Surg; 2006 Dec; 203(6):878-86. PubMed ID: 17116556
[TBL] [Abstract][Full Text] [Related]
56. Phase I trial of pegylated liposomal doxorubicin with hyperthermic intraperitoneal chemotherapy in patients undergoing cytoreduction for advanced intra-abdominal malignancy.
Harrison LE; Bryan M; Pliner L; Saunders T
Ann Surg Oncol; 2008 May; 15(5):1407-13. PubMed ID: 18157576
[TBL] [Abstract][Full Text] [Related]
57. Laparoscopic intraperitoneal chemohyperthermia (IPCH) for gastrointestinal malignancies: indications and results.
Chouillard E
Minerva Chir; 2008 Dec; 63(6):497-509. PubMed ID: 19078882
[TBL] [Abstract][Full Text] [Related]
58. Prognostic analysis of clinicopathologic factors in 49 patients with diffuse malignant peritoneal mesothelioma treated with cytoreductive surgery and intraperitoneal hyperthermic perfusion.
Deraco M; Nonaka D; Baratti D; Casali P; Rosai J; Younan R; Salvatore A; Cabras Ad AD; Kusamura S
Ann Surg Oncol; 2006 Feb; 13(2):229-37. PubMed ID: 16444562
[TBL] [Abstract][Full Text] [Related]
59. Operability and early outcome in 100 consecutive laparotomies for peritoneal malignancy.
Moran BJ; Mukherjee A; Sexton R
Br J Surg; 2006 Jan; 93(1):100-4. PubMed ID: 16302177
[TBL] [Abstract][Full Text] [Related]
60. Pseudomyxoma peritonei: biological features are the dominant prognostic determinants after complete cytoreduction and hyperthermic intraperitoneal chemotherapy.
Baratti D; Kusamura S; Nonaka D; Cabras AD; Laterza B; Deraco M
Ann Surg; 2009 Feb; 249(2):243-9. PubMed ID: 19212177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
